Resultats globals: 5 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
8 p, 715.4 KB Head and neck cancers survival in Europe, Taiwan, and Japan : results from RARECAREnet Asia based on a privacy-preserving federated infrastructure / Botta, Laura (Department of Epidemiology and Data Science. Fondazione IRCCS Istituto Nazionale dei Tumori) ; Matsuda, Tomohiro (Insititute of Cancer Control. National Cancer Center (Japò)) ; Charvat, Hadrien (National Cancer Center (Japò)) ; Chiang, Chung-Ju (Taiwan Cancer Registry Center) ; Lee, Wen-Chung (Taiwan Cancer Registry Center) ; van Gestel, Anna Jacoba (Department of Research & Development. Netherlands Comprehensive Cancer Organisation) ; Martin, Frank (Department of Research & Development. Netherlands Comprehensive Cancer Organisation) ; Geleijnse, Gijs (Department of Research & Development. Netherlands Comprehensive Cancer Organisation) ; Cellamare, Mattheo (Department of Research & Development. Netherlands Comprehensive Cancer Organisation) ; Bonfarnuzzo, Simone (Department of Epidemiology and Data Science. Fondazione IRCCS Istituto Nazionale dei Tumori) ; Marcos-Gragera, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Guevara, Marcela (Instituto de Investigación Sanitaria de Navarra) ; Mousavi, Mohsen (East Switzerland Cancer Registry) ; Craig, Stefano (Queen's University Belfast) ; Rodrigues, Jessica (Porto Comprehensive Cancer Centre (Portugal)) ; Rubió-Casadevall, Jordi (Institut de Recerca Biomèdica de Lleida) ; Licitra, Lisa (Department of Oncology and Hemato-Oncology. University of Milan) ; Cavalieri, Stephanie (Department of Oncology and Hemato-Oncology. University of Milan) ; Resteghini, Carlo (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ; Gatta, Gemma (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ; Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano)
Background: The head and neck cancers (HNCs) incidence differs between Europe and East Asia. Our objective was to determine whether survival of HNC also differs between European and Asian countries. [...]
2023 - 10.3389/fonc.2023.1219111
Frontiers in Oncology, Vol. 13 (2023) , p. 1219111  
2.
15 p, 942.2 KB A growth modulation index-based geistra score as a new prognostic tool for trabectedin efficacy in patients with advanced soft tissue sarcomas : A Spanish group for sarcoma research (GEIS) retrospective study / Martínez-Trufero, Javier (Hospital Universitario Miguel Servet (Saragossa)) ; Sande-González, Luis Miguel de (Hospital Universitario de León) ; Luna, Pablo (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Martín-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Alvarez, Rosa (Hospital General Universitario Gregorio Marañón) ; Marquina, Gloria (Hospital Universitario Clínico San Carlos (Madrid)) ; Diaz-Beveridge, Roberto (Hospital Universitari i Politècnic La Fe (València)) ; Poveda, Andrés (Instituto Valenciano de Oncologia) ; Cano, Juana María (Hospital General de Ciudad Real) ; Cruz-Jurado, Josefina (Hospital Universitario Canarias) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Salgado, María Angeles Vaz (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Valverde-Morales, Claudia Maria. (Hospital Universitari Vall d'Hebron) ; Sevilla, Isabel (Universitarios Regional y Virgen de la Victoria de Málaga) ; Martínez-García, Jerónimo (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Rubio-Casadevall, Jordi (Institut Català d'Oncologia) ; de Juan Ferre, Ana (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Carrasco, Juan Antonio (Hospital Álvaro Cunqueiro (Vigo)) ; Moura, David S. (Instituto de Biomedicina de Sevilla) ; Gurruchaga-Sotes, Ibon (Hospital Universitario Miguel Servet (Saragossa)) ; Gutiérrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears))
The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. [...]
2021 - 10.3390/cancers13040792
Cancers, Vol. 13 Núm. 4 (february 2021) , p. 1-15  
3.
15 p, 733.1 KB A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin / Moura, David S. (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ; Peña-Chilet, María (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Cordero Varela, Juan Antonio (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ; Alvarez-Alegret, Ramiro (Hospital Universitario Miguel Servet (Saragossa)) ; Agra-Pujol, Carolina (Hospital General Universitario Gregorio Marañón) ; Izquierdo, Francisco (Complejo Asistencial Universitario de León) ; Ramos, Rafael (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Ortega-Medina, Luis (Hospital Clínico San Carlos (Madrid)) ; Martin-Davila, Francisco (Ciudad Real General Hospital) ; Castilla-Ramirez, Carolina (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Hernandez-Leon, Carmen Nieves (Hospital Universitario de Canarias (La Laguna)) ; Romagosa, Cleofe (Hospital Universitari Vall d'Hebron) ; Vaz Salgado, María Ángeles (Hospital Universitario Ramón y Cajal (Madrid)) ; Lavernia, Javier (Instituto Valenciano de Oncologia) ; Bagué Rosell, Sílvia (Institut d'Investigació Biomèdica Sant Pau) ; Mayodormo-Aranda, Empar (Hospital Universitari i Politècnic La Fe (València)) ; Vicioso, Luis (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Hernández Barceló, José Emilio (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ; Rubio-Casadevall, Jordi (Hospital Universitari de Girona Doctor Josep Trueta) ; de Juan, Ana (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Fiaño-Valverde, María Concepción (Hospital Álvaro Cunqueiro (Vigo)) ; Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Lopez-Alvarez, María (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ; Lacerenza, Serena (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ; Dopazo, Joaquín (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Gutiérrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Alvarez, Rosa (Hospital General Universitario Gregorio Marañón) ; Valverde, Claudia (Hospital Universitari Vall d'Hebron) ; Martínez-Trufero, Javier (Hospital Universitario Miguel Servet (Saragossa)) ; Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Predictive biomarkers of trabectedin represent an unmet need in advanced soft-tissue sarcomas (STS). DNA damage repair (DDR) genes, involved in homologous recombination or nucleotide excision repair, had been previously described as biomarkers of trabectedin resistance or sensitivity, respectively. [...]
2021 - 10.1002/1878-0261.12996
Molecular Oncology, Vol. 15 Núm. 12 (december 2021) , p. 3691-3705  
4.
11 p, 394.8 KB Effects of free leucine supplementation and resistance training on muscle strength and functional status in older adults : a randomized controlled trial / Trabal, Joan (Hospital Clínic i Provincial de Barcelona) ; Forga-Martel, Maria (Hospital Clínic i Provincial de Barcelona) ; Leyes, Pere (Hospital Clínic i Provincial de Barcelona) ; Torres, Ferran (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Rubio, Jordi (Residencia Ballesol Almogavers, Grupo Ballesol, Barcelona) ; Prieto, Esther (Fundació Amiba (Badalona, Catalunya)) ; Farran-Codina, Andreu (Universitat de Barcelona. Departament de Nutrició, Ciències de l'Alimentació i Gastronomia)
To assess the effect of free leucine supplementation combined with resistance training versus resistance training only on muscle strength and functional status in older adults. This was a randomized, double-blind, placebo-controlled, parallel study with two intervention groups. [...]
2015 - 10.2147/CIA.S75271
Clinical Interventions in Aging, Vol. 10 (april 2015) , p. 713-723  
5.
9 p, 403.1 KB Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors : a population-based study / Rubió Casadevall, Jordi (Institut Català d'Oncologia) ; Borràs, Joan Lluis (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Carmona-Garcia, M. Carmen (Institut d'Investigació Biomèdica de Girona) ; Ameijide, Alberto (Universitat Rovira i Virgili. Fundació per a la Investigació i Prevenció del Càncer) ; Gonzalez-Vidal, Allan (Institut d'Investigació Biomèdica Sant Pau) ; Ortiz, Maria Rosa (Hospital Universitari de Girona Doctor Josep Trueta) ; Bosch Príncep, Ramon (Hospital de Tortosa Verge de la Cinta) ; Riu, Francesc (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Parada, David (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Martí, Esther (Hospital Sant Pau i Santa Tecla (Tarragona)) ; Miró, Josefina (Clinica Girona Departament de Patologia) ; Sirvent, Juan Jose (Hospital Universitari Joan XXIII de Tarragona) ; Galceran, Jaume (Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain) ; Marcos-Gragera, Rafael (Institut d'Investigació Biomèdica de Girona) ; Universitat Autònoma de Barcelona
Gastrointestinal stromal tumors are sarcomas of the digestive tract characterized by mutations mainly located in the c-KIT or in the platelet-derived growth factor receptor (PDGFR)-alpha genes. Mutations in the BRAF gene have also been described. [...]
2015 - 10.1186/s12957-015-0474-0
World Journal of Surgical Oncology, Vol. 13 (february 2015)  

Vegeu també: autors amb noms similars
5 Rubio, J.
7 Rubio, J. A.
1 Rubio, J.A.
1 Rubio, Jorge
2 Rubio, Jose
1 Rubio, Josep E.
1 Rubio, José Manuel
1 Rubio, Juan C.
10 Rubio, Juan Carlos
1 Rubio, Juanjo
1 Rubió, Jean
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.